Associated Genetic Biomarkers
FYN proto-oncogene, Src family tyrosine kinase (FYN) is a gene that encodes a protein that functions as a membrane-associated tyrosine kinase that regulates cell growth. Missense mutations, nonsense mutations, silent mutations, and frameshift insertions are observed in cancers such as intestinal cancer, skin cancer, and stomach cancer.
FYN is altered in 1.02% of all cancers with breast invasive ductal carcinoma, lung adenocarcinoma, colon adenocarcinoma, prostate adenocarcinoma, and endometrial endometrioid adenocarcinoma having the greatest prevalence of alterations .
The most common alterations in FYN are FYN Mutation (0.63%), FYN Loss (0.26%), FYN Amplification (0.15%), FYN E107Q (0.01%), and FYN R206C (0.01%) .
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.